US2016317628A1PendingUtilityA1

Serpin drugs for treatment of viral infection and method of use thereof

26
Assignee: GEIBEN-LYNN RALFPriority: Jan 26, 2001Filed: Jul 20, 2016Published: Nov 3, 2016
Est. expiryJan 26, 2021(expired)· nominal 20-yr term from priority
Inventors:Ralf Geiben-Lynn
A61P 31/14A61P 31/18A61P 31/20A61P 31/22A61P 1/16A61K 38/57A61K 31/727A61K 47/6911A61K 9/127
26
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention includes a heparin activated Antithrombin III encapsulated into a sterically stabilized anti-HLA-DR immunoliposome for the treatment of a HIV infection in a human patient.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising a therapeutically effective amount of 43 kDa modified antithrombin. 
     
     
         2 . The composition of  claim 1 , further comprising a pharmaceutically acceptable carrier or diluent. 
     
     
         3 . The composition of  claim 1 , wherein said composition is associated with a surface. 
     
     
         4 . The composition of  claim 3 , wherein said surface is a bead, chip, column or matrix.

Join the waitlist — get patent alerts

Track US2016317628A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.